DK2968529T3 - Fremstilling af jordnøddeformuleringer til oral desensibilisering - Google Patents

Fremstilling af jordnøddeformuleringer til oral desensibilisering Download PDF

Info

Publication number: DK2968529T3
Authority: DK; Denmark
Prior art keywords: peanuty; desensibilization; formulations; oral; preparation
Prior art date: 2013-03-14

Application number

DK14776121.7T

Other languages

English (en)

Inventor

Bryan Walser

Howard V Raff

Original Assignee

Aimmune Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-03-14

Filing date

2014-03-12

Publication date

2020-10-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51528061&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2968529(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-03-12 Application filed by Aimmune Therapeutics Inc filed Critical Aimmune Therapeutics Inc

2020-10-12 Application granted granted Critical

2020-10-12 Publication of DK2968529T3 publication Critical patent/DK2968529T3/da

Links

239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Natural Medicines & Medicinal Plants (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Microbiology (AREA)
Botany (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Transplantation (AREA)
Medical Informatics (AREA)
Pulmonology (AREA)
Alternative & Traditional Medicine (AREA)
Biotechnology (AREA)
Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Plant Substances (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

DK14776121.7T 2013-03-14 2014-03-12 Fremstilling af jordnøddeformuleringer til oral desensibilisering DK2968529T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201361784964P	2013-03-14	2013-03-14
PCT/US2014/024401 WO2014159607A1 (en)	2013-03-14	2014-03-12	Manufacture of peanut formulations for oral desensitization

Publications (1)

Publication Number	Publication Date
DK2968529T3 true DK2968529T3 (da)	2020-10-12

Family

ID=51528061

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK14776121.7T DK2968529T3 (da)	2013-03-14	2014-03-12	Fremstilling af jordnøddeformuleringer til oral desensibilisering
DK18213124.3T DK3482771T3 (da)	2013-03-14	2014-03-12	Fremstilling af jordnøddeformuleringer til oral desensibilisering

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK18213124.3T DK3482771T3 (da)	2013-03-14	2014-03-12	Fremstilling af jordnøddeformuleringer til oral desensibilisering

Country Status (19)

Country	Link
US (5)	US9198869B2 (da)
EP (3)	EP3482771B1 (da)
JP (3)	JP6752140B2 (da)
CN (2)	CN109125283A (da)
AU (5)	AU2014240404B2 (da)
BR (1)	BR112015021756B1 (da)
CA (1)	CA2903229A1 (da)
DK (2)	DK2968529T3 (da)
ES (2)	ES2826224T3 (da)
FI (2)	FI3482771T3 (da)
FR (1)	FR23C1026I2 (da)
HU (1)	HUE051831T2 (da)
MX (1)	MX2015010315A (da)
NL (1)	NL301236I2 (da)
NO (1)	NO2023027I1 (da)
PL (1)	PL2968529T3 (da)
PT (1)	PT2968529T (da)
SI (1)	SI2968529T1 (da)
WO (1)	WO2014159607A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2924349B1 (fr)	2007-12-03	2010-01-01	Dbv Tech	Methode de desensibilitation aux allergenes
MX2015010315A (es)	2013-03-14	2016-04-13	Aimmune Therapeutics Inc	Fabricacion de formulaciones de mani para desensibilizacion oral.
WO2014159609A1 (en)	2013-03-14	2014-10-02	Allergen Research Corporation	Peanut formulations and uses thereof
JP6910946B2 (ja)	2014-08-25	2021-07-28	アイミューンセラピューティクス，インコーポレイテッド	タマゴのタンパク質製剤およびその製造方法
MA41020A (fr)	2014-11-25	2017-10-03	Evelo Biosciences Inc	Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US10166286B2 (en)	2015-02-20	2019-01-01	The Board Of Trustees Of The Leland Stanford Junior University	Mixed allergen compositions and methods for using the same
WO2016134291A2 (en)	2015-02-20	2016-08-25	The Board Of Trustees Of The Leland Stanford Junior University	Mixed allergen compositions and methods for using the same
US11452774B2 (en)	2015-02-20	2022-09-27	The Board Of Trustees Of The Leland Stanford Junior University	Mixed allergen compositions and methods for using the same
US10143742B2 (en)	2015-02-20	2018-12-04	The Board Of Trustees Of The Leland Stanford Junior University	Mixed allergen compositions and methods for using the same
US10149904B2 (en)	2015-02-20	2018-12-11	The Board Of Trusteees Of The Leland Stanford Junior University	Mixed allergen compositions and methods for using the same
TW201709926A (zh) *	2015-04-23	2017-03-16	賽諾菲公司	用於舌下投藥之吡喃葡萄糖基脂ａ及過敏原調配物
US10856567B2 (en)	2016-07-22	2020-12-08	Kari Brown	Baby food products containing allergenic proteins and methods of delivering same
PT3548079T (pt) *	2016-12-05	2023-07-27	Reacta Biotech Ltd	Formulações de refeições para provocação oral
CN110381749A (zh) *	2017-01-13	2019-10-25	艾慕恩治疗公司	坚果粉的制造方法和用于口服免疫疗法的配方
AU2017279647B2 (en)	2017-02-15	2022-05-26	Euroimmun Medizinische Labordiagnostika Ag	An improved assay for the diagnosis of peanut allergy
CN111465328A (zh)	2017-07-18	2020-07-28	前品牌股份有限公司	制备混合型变应原组合物的方法
US11369676B2 (en)	2017-11-02	2022-06-28	Société des Produits Nestlé S.A.	Methods of oral immunotherapy
GB201718342D0 (en) *	2017-11-06	2017-12-20	Cambridge Allergy Ltd	Allergenic protein formulations for immunotherapy
EP3740223A4 (en)	2018-01-16	2021-10-20	Tel HaShomer Medical Research Infrastructure and Services Ltd.	TREATMENT AND PREVENTION OF SEED ALLERGIES
US11406563B2 (en)	2018-07-27	2022-08-09	Société des Produits Nestlé S.A.	Oral immunotherapy unit dose dispensing systems and methods
US12433945B2 (en)	2018-08-16	2025-10-07	Société des Produits Nestlé S.A.	Peanut oral immunotherapy with maintenance dose
AU2019401576A1 (en) *	2018-12-17	2021-06-24	Société des Produits Nestlé S.A.	Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy
CA3123605A1 (en) *	2018-12-20	2020-06-25	Aimmune Therapeutics, Inc.	Peanut oral immunotherapy dosing schedule for missed doses
US11766477B2 (en)	2019-01-23	2023-09-26	Societe Des Produits Nestle S.A.	Methods for making mixed allergen compositions
CA3137295A1 (en)	2019-05-10	2020-11-19	Aimmune Therapeutics, Inc.	Methods for improving the quality of life of a patient with a peanut allergy
ES3038192T3 (en) *	2019-08-08	2025-10-10	Evonik Operations Gmbh	Method of preparing a solid dosage form and a lubricant
WO2021102186A1 (en) *	2019-11-20	2021-05-27	Aimmune Therapeutics, Inc.	Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug
AU2020410909A1 (en) *	2019-12-23	2022-07-14	Prota Therapeutics Pty Ltd	Pharmaceutical compositions
JP7756664B2 (ja)	2020-07-01	2025-10-20	ソシエテ・デ・プロデュイ・ネスレ・エス・アー	経口免疫療法のための医療スタッフ配置の決定
US20220220211A1 (en)	2021-01-08	2022-07-14	Regeneron Pharmaceuticals, Inc.	Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist
US20250325658A1 (en)	2022-04-11	2025-10-23	Alk-Abelló A/S	Peanut allergen compositions

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3809767A (en)	1969-05-12	1974-05-07	Griffith Laboratories	Methods of making vegetable protein concentrates
AU1589492A (en)	1991-03-01	1992-10-06	Warner-Lambert Company	Starch-based controlled release compositions
US20120164306A1 (en) *	1993-08-03	2012-06-28	Girsh Leonard S	Process for preparing hypoallergenic and reduced fat foods
JP3445593B2 (ja) *	1994-09-10	2003-09-08	株式会社林原生物化学研究所	ペプチドとその用途
US20020018778A1 (en)	1999-12-06	2002-02-14	Caplan Michael J.	Passive desensitization
EP1272213B1 (en) *	2000-04-06	2006-03-08	SEER Pharmaceuticals, LLC.	Microbial delivery system
CA2516291C (en)	2003-02-28	2012-02-14	Alk-Abello A/S	Dosage form having a saccharide matrix
EP2545931A1 (en)	2004-03-19	2013-01-16	Herbs Spring, LLC	Herbal therapy for the treatment of food allergy
WO2007075171A1 (en)	2005-12-28	2007-07-05	Teva Pharmaceutical Industries Ltd.	Pharmaceutical formulations of fenofibrate having improved bioavailability
FR2924349B1 (fr) *	2007-12-03	2010-01-01	Dbv Tech	Methode de desensibilitation aux allergenes
CN102215825A (zh)	2008-11-19	2011-10-12	安万托特性材料股份有限公司	可直接压制的颗粒状的基于微晶纤维素的赋形剂、其制备方法及应用
WO2010069595A1 (en)	2008-12-19	2010-06-24	Merz Pharma Gmbh & Co. Kgaa	1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
US8329208B2 (en) *	2009-07-28	2012-12-11	Methylation Sciences International Srl	Pharmacokinetics of S-adenosylmethionine formulations
EP2364690A1 (en) *	2010-02-12	2011-09-14	Centro De Ingenieria Genetica Y Biotecnologia	Orally administrable pharmaceutical pellet of epidermal growth factor
JP5800527B2 (ja)	2010-03-30	2015-10-28	日東電工株式会社	安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
AR081776A1 (es)	2010-06-30	2012-10-17	Novartis Ag	Composiciones farmaceuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona, proceso para la produccion de la composicion
CN101912364B (zh) *	2010-08-09	2015-07-15	刘会梅	银杏内酯b脂质体组合药物
GB201104537D0 (en) *	2011-03-17	2011-05-04	Cambridge Entpr Ltd	Treatment for peanut allergy
EP2750705B1 (en) *	2011-08-31	2022-11-16	Perosphere Technologies Inc.	Methods for effectively and rapidly desensitizing allergic patients
WO2013087119A1 (en)	2011-12-16	2013-06-20	Hal Allergy Holding B.V.	Pharmaceutical formulations and the use thereof for the treatment of peanut allergy
MX2015010315A (es)	2013-03-14	2016-04-13	Aimmune Therapeutics Inc	Fabricacion de formulaciones de mani para desensibilizacion oral.
WO2014159609A1 (en)	2013-03-14	2014-10-02	Allergen Research Corporation	Peanut formulations and uses thereof
JP6910946B2 (ja)	2014-08-25	2021-07-28	アイミューンセラピューティクス，インコーポレイテッド	タマゴのタンパク質製剤およびその製造方法
CN110381749A (zh)	2017-01-13	2019-10-25	艾慕恩治疗公司	坚果粉的制造方法和用于口服免疫疗法的配方
US11369676B2 (en)	2017-11-02	2022-06-28	Société des Produits Nestlé S.A.	Methods of oral immunotherapy

2014
- 2014-03-12 MX MX2015010315A patent/MX2015010315A/es unknown
- 2014-03-12 DK DK14776121.7T patent/DK2968529T3/da active
- 2014-03-12 US US14/207,165 patent/US9198869B2/en active Active
- 2014-03-12 ES ES14776121T patent/ES2826224T3/es active Active
- 2014-03-12 DK DK18213124.3T patent/DK3482771T3/da active
- 2014-03-12 ES ES18213124T patent/ES2940686T3/es active Active
- 2014-03-12 AU AU2014240404A patent/AU2014240404B2/en active Active
- 2014-03-12 WO PCT/US2014/024401 patent/WO2014159607A1/en not_active Ceased
- 2014-03-12 EP EP18213124.3A patent/EP3482771B1/en active Active
- 2014-03-12 EP EP14776121.7A patent/EP2968529B1/en active Active
- 2014-03-12 FI FIEP18213124.3T patent/FI3482771T3/fi active
- 2014-03-12 CA CA2903229A patent/CA2903229A1/en active Pending
- 2014-03-12 EP EP21199373.8A patent/EP3998080A1/en active Pending
- 2014-03-12 SI SI201431687T patent/SI2968529T1/sl unknown
- 2014-03-12 PL PL14776121T patent/PL2968529T3/pl unknown
- 2014-03-12 BR BR112015021756-7A patent/BR112015021756B1/pt active IP Right Grant
- 2014-03-12 CN CN201811093370.9A patent/CN109125283A/zh active Pending
- 2014-03-12 JP JP2016501522A patent/JP6752140B2/ja active Active
- 2014-03-12 CN CN201480013792.4A patent/CN105101994B/zh active Active
- 2014-03-12 PT PT147761217T patent/PT2968529T/pt unknown
- 2014-03-12 HU HUE14776121A patent/HUE051831T2/hu unknown
2015
- 2015-10-13 US US14/881,437 patent/US20160030289A1/en not_active Abandoned
2016
- 2016-09-21 AU AU2016231523A patent/AU2016231523B2/en active Active
2017
- 2017-10-24 US US15/792,716 patent/US10449118B2/en active Active
2018
- 2018-08-30 AU AU2018222980A patent/AU2018222980A1/en not_active Abandoned
2019
- 2019-02-27 JP JP2019034083A patent/JP6891205B2/ja active Active
- 2019-06-26 US US16/453,871 patent/US11141352B2/en active Active
2020
- 2020-04-22 AU AU2020202685A patent/AU2020202685B2/en active Active
2021
- 2021-02-19 JP JP2021025462A patent/JP7454519B2/ja active Active
2022
- 2022-03-17 AU AU2022201858A patent/AU2022201858B2/en active Active
- 2022-09-20 US US17/948,611 patent/US20230120350A1/en not_active Abandoned
2023
- 2023-07-03 NL NL301236C patent/NL301236I2/nl unknown
- 2023-07-04 FI FIC20230022C patent/FIC20230022I1/fi unknown
- 2023-07-06 NO NO2023027C patent/NO2023027I1/no unknown
- 2023-07-07 FR FR23C1026C patent/FR23C1026I2/fr active Active

Also Published As

Publication number	Publication date
US11141352B2 (en)	2021-10-12
US20160030289A1 (en)	2016-02-04
FI3482771T3 (fi)	2023-04-03
FR23C1026I1 (fr)	2023-10-06
JP2016512537A (ja)	2016-04-28
JP2021073321A (ja)	2021-05-13
SI2968529T1 (sl)	2021-03-31
BR112015021756A2 (pt)	2017-07-18
AU2020202685A1 (en)	2020-05-14
EP3482771B1 (en)	2023-01-18
NO2023027I1 (no)	2023-07-06
AU2018222980A1 (en)	2018-09-20
ES2940686T3 (es)	2023-05-10
US20200129378A1 (en)	2020-04-30
US10449118B2 (en)	2019-10-22
BR112015021756A8 (pt)	2019-11-19
DK3482771T3 (da)	2023-03-20
MX2015010315A (es)	2016-04-13
WO2014159607A1 (en)	2014-10-02
CN105101994B (zh)	2018-10-12
FR23C1026I2 (fr)	2024-07-26
EP2968529A1 (en)	2016-01-20
PT2968529T (pt)	2020-11-10
BR112015021756B1 (pt)	2023-01-10
ES2826224T3 (es)	2021-05-17
NL301236I2 (nl)	2025-07-31
US20180042816A1 (en)	2018-02-15
EP3482771A1 (en)	2019-05-15
AU2020202685B2 (en)	2022-01-20
HK1217660A1 (zh)	2017-01-20
EP2968529B1 (en)	2020-08-05
US9198869B2 (en)	2015-12-01
US20140271836A1 (en)	2014-09-18
PL2968529T3 (pl)	2021-04-19
EP3998080A1 (en)	2022-05-18
AU2016231523B2 (en)	2018-05-31
US20230120350A1 (en)	2023-04-20
CN109125283A (zh)	2019-01-04
AU2014240404A1 (en)	2015-09-17
CA2903229A1 (en)	2014-10-02
JP6752140B2 (ja)	2020-09-09
AU2022201858B2 (en)	2024-04-04
FIC20230022I1 (fi)	2023-07-04
EP2968529A4 (en)	2016-10-05
AU2022201858A1 (en)	2022-04-07
AU2016231523A1 (en)	2016-10-06
JP7454519B2 (ja)	2024-03-22
CN105101994A (zh)	2015-11-25
AU2014240404B2 (en)	2016-07-21
JP6891205B2 (ja)	2021-06-18
HUE051831T2 (hu)	2021-03-29
JP2019108357A (ja)	2019-07-04

Publication	Publication Date	Title
DK3482771T3 (da)	2023-03-20	Fremstilling af jordnøddeformuleringer til oral desensibilisering
DK3725778T4 (da)	2026-02-09	Formuleringer af enzalutamid
IL246025B (en)	2022-02-01	Formulations for neoplasia vaccines
EP3065716C0 (en)	2023-12-20	FORMULATIONS
DK2845905T3 (da)	2021-06-14	Fremstilling af oligosaccharider
DK3157508T3 (da)	2021-02-15	Fast oral doseringsform af lipofile forbindelser
DK3454346T3 (da)	2021-11-01	Anordning til cylotronfremstilling af technetium-99m
DK3611262T3 (da)	2021-01-25	Fremgangsmåder til sekvensering af immunrepertoire
DK2968071T3 (da)	2021-11-08	Enhed til oral levering af terapeutiske forbindelser
PT3030262T (pt)	2019-12-11	Composição farmacêutica de associação
HUE040609T2 (hu)	2019-03-28	GLP-1 vegyületek orális adagolása
DK2961766T3 (da)	2019-07-15	Kvantificering af vaccinesammensætninger
DK2968221T3 (da)	2019-08-05	Farmaceutisk sammensætning af s-ketaminhydrochlorid
DK3052080T3 (da)	2025-08-18	Langtidsvirkende spiro-isoxalin-formuleringer
PL2964202T3 (pl)	2019-04-30	Doustne formulacje deferazyroksu
HUE052981T2 (hu)	2021-05-28	Linaklotid késleltetett leadású készítményei
PT3089754T (pt)	2021-07-23	Formulações de vacina de dose única
DK3185853T3 (da)	2024-02-26	Inhalerbare pulverformuleringer af alginatoligomerer
IL245855A0 (en)	2016-07-31	Oral formulations of pyrrolidine derivatives
DK3106150T3 (da)	2021-11-01	Forbedrede farmaceutiske sammensætninger af pimobendan
DK3010895T3 (da)	2017-11-20	Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
EP2958994A4 (en)	2016-11-23	Vaccine composition
DK2931313T3 (da)	2019-07-15	Opløsningsformuleringer af manipulerede anti-il-23p19-antistoffer
EP2961397A4 (en)	2016-11-02	TRANSDERMAL FORMULATIONS
DK2981258T3 (da)	2020-10-19	Farmaceutiske formuleringer til subkutan indgivelse af furosemid